Applications for this meeting must be submitted by May 6, 2017. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the Conference Chair if more seats become available due to cancellations.
GRS Speaker Abstract Deadline: Although applications will be accepted until the date noted above, any applicants who wish to be considered for an oral presentation should submit their application by March 27, 2017. Please refer to the application instructions in the Meeting Description section below for more details (if available).
The Gordon Research Seminar on Preclinical Form and Formulation for Drug Discovery is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.
The focus of this
meeting is on recent progress in understanding and new strategies in preclinical drug
development including conventional formulations as well as novel therapies. Discussion
topics include, but are not limited to, new approaches in enhancing solubility
of poorly-soluble drugs, protein stability, targeted drug delivery, and new analytical
methodologies. Additionally, experts in academia and industry will share their
experience and provide a general perspective on the future of pharmaceutical research.
The meeting will feature approximately 10 talks and 2 poster sessions. All attendees are expected to actively participate in the GRS either by giving an oral presentation or presenting a poster. Therefore, all applications must include an abstract.
The Chairs will select speakers from abstracts submitted by March 27, 2017. Those applicants who are not chosen for talks and those who apply after the deadline to be considered for an oral presentation will be expected to present a poster. In order to participate, you must submit an application by the date indicated in the Application Deadline section above.
This GRS will be held in conjunction with the "Preclinical Form & Formulation for Drug Discovery" Gordon Research Conference (GRC)
. Those interested in attending both meetings must submit an application for the GRC in addition to an application for the GRS. Refer to the associated GRC program page
for more information.
|2:00 pm - 5:00 pm||Arrival and Check-in|
|3:30 pm - 3:45 pm||Introductory Comments by GRC Site Staff / Welcome by the GRS Conference Chair|
|3:45 pm - 4:30 pm||Keynote Session: Preclinical Form and Formulation for Drug Discovery|
|Discussion Leader: Narayan Variankaval (Merck Research Laboratories, USA)|
|3:45 pm - 4:20 pm||Nicholas Warne (Pfizer, USA)|
"Biotechnology Dosage Form Development for the Rapidly Evolving Healthcare Environment"
|4:20 pm - 4:30 pm||Discussion|
|4:30 pm - 6:00 pm||Poster Session|
|7:30 pm - 9:30 pm||Parenteral Formulations: Characterization and Stability|
|Discussion Leaders: Adora Padilla (GSK Vaccines, USA) and Adrian Defante (National Institute of Standards and Technology, USA)|
|7:30 pm - 7:50 pm||Ashley Lay (University of Kentucky, USA)|
"Solid-State NMR Spectroscopy: A Versatile Tool for Characterizing Lyophilized Protein Formulations"
|7:50 pm - 8:00 pm||Discussion|
|8:00 pm - 8:20 pm||Carly Chisholm (University of Colorado Boulder, USA)|
"Stability of Therapeutic Protein Formulations in Novel Cyclic Olefin Polymer Vials and Syringes Containing Silica-Coated Surfaces"
|8:20 pm - 8:30 pm||Discussion|
|8:30 pm - 8:50 pm||Shreya Kulkarni (University of Connecticut, USA)|
"Why Does Crystallization of Mannitol Lower the Reconstitution Times of Freeze-Dried Highly Concentrated Protein Formulations?"
|8:50 pm - 9:00 pm||Discussion|
|9:00 pm - 9:20 pm||Rikhav Gala (Mercer University, USA)|
"Formulation and Preclinical Evaluation of a Novel Buccal and Transdermal Measles Vaccine"
|9:20 pm - 9:30 pm||Discussion|
|7:30 am - 8:30 am||Breakfast|
|9:00 am - 11:00 am||Oral Dosage Forms: Drug Delivery and Formulation|
|Discussion Leaders: Sachin Lohani (Johnson & Johnson, USA) and Alpana Thorat (Purdue University, USA)|
|9:00 am - 9:20 am||Peng Yu (The University of Iowa, USA)|
"Thermodynamic Understanding of Enthalpy-Driven Adsorption Phenomena: Phenobarbital and Activated Carbons as the Model System"
|9:20 am - 9:30 am||Discussion|
|9:30 am - 9:50 am||Sampada Koranne (University of Minnesota, USA)|
"Investigation of Spatial Heterogeneity of Salt Disproportionation in Tablets by Synchrotron X-Ray Diffractometry"
|9:50 am - 10:00 am||Discussion|
|10:00 am - 10:20 am||Julie Calahan (University of Kentucky, USA)|
"Correlating the Effect of Physicochemical Properties of Magnesium Stearate with Indomethacin Tablet Dissolution"
|10:20 am - 10:30 am||Discussion|
|10:30 am - 10:50 am||Bart Hens (University of Michigan, USA)|
"Formulation Predictive Dissolution (fPD) for Oral Drug Products"
|10:50 am - 11:00 am||Discussion|
|11:00 am - 12:30 pm||Poster Session|
|Coffee will be served in the poster area from 11:00 am - 11:30 am|
|1:30 pm - 2:30 pm||Mentorship Component: Career Panel|
|Discussion Leader: Yongchao Su (Merck Research Laboratories, USA)|
|1:30 pm - 2:30 pm||Panel Discussion|
|"Careers in Pharmaceutical Sciences"|
- Annette Bak (AstraZeneca, Sweden)
- Robert Berendt (U.S. Food and Drug Administration, USA)
- Elizabeth Topp (Purdue University, USA)
|2:30 pm - 3:00 pm||Evaluation Period|
|Fill in GRS Evaluation Forms|
|3:00 pm||Seminar Concludes|